Klaus Kølendorf

1.3k total citations
50 papers, 905 citations indexed

About

Klaus Kølendorf is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Klaus Kølendorf has authored 50 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Surgery. Recurrent topics in Klaus Kølendorf's work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (13 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers). Klaus Kølendorf is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes Treatment and Management (13 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers). Klaus Kølendorf collaborates with scholars based in Denmark, United States and Norway. Klaus Kølendorf's co-authors include Sten Madsbad, T. Deckert, B Staberg, Kjeld Hermansen, Michele Colombo, Heidi Storgaard, Anette Østergaard, Klaus Levin, Birgitte Brock and O. Schmitz and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Diabetes Care.

In The Last Decade

Klaus Kølendorf

49 papers receiving 823 citations

Peers

Countries citing papers authored by Klaus Kølendorf

Since Specialization

Citations

This map shows the geographic impact of Klaus Kølendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Kølendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Kølendorf more than expected).

Fields of papers citing papers by Klaus Kølendorf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Kølendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Kølendorf. The network helps show where Klaus Kølendorf may publish in the future.

Co-authorship network of co-authors of Klaus Kølendorf

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Kølendorf. A scholar is included among the top collaborators of Klaus Kølendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Kølendorf. Klaus Kølendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus 2008 ·Diabetic Medicine ·(unknown), Birgitte Brock, Hans Perrild, Klaus Levin, Hans-Henrik Lervang, Klaus Kølendorf, Thure Krarup, O. Schmitz, Milan Zdravković, T Le-Thi, Sten Madsbad	183
2	Four-fold increase in foot ulcers in type 2 diabetic subjects without an increase in major amputations by a multidisciplinary setting 2008 ·Diabetes Research and Clinical Practice ·Christoffer Hedetoft, Anne Rasmussen, (unknown), Klaus Kølendorf	21
3	Lower Risk of Hypoglycemia with Insulin Detemir than with Neutral Protamine Hagedorn Insulin in Older Persons with Type 2 Diabetes: A Pooled Analysis of Phase III Trials 2007 ·Journal of the American Geriatrics Society ·Alan J. Garber, Per Clauson, (unknown), Klaus Kølendorf	40
4	Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes 2006 ·Diabetic Medicine ·Klaus Kølendorf, Glynis P. Ross, (unknown), G. Perriello, Areti Philotheou, Johan Jendle, (unknown), Simon Heller	94
5	Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes 2003 ·Diabetes Research and Clinical Practice ·Klaus Kølendorf, Johan G. Eriksson, Kåre I. Birkeland, Thomas Kjellström, Ástráður B. Hreiðarsson	2
6	Improved Postprandial Glycemic Control With Biphasic Insulin Aspart Relative to Biphasic Insulin Lispro and Biphasic Human Insulin in Patients With Type 2 Diabetes 2002 ·Diabetes Care ·Kjeld Hermansen, Michele Colombo, Heidi Storgaard, Anette Østergaard, Klaus Kølendorf, Sten Madsbad	107
7	Clinical experience with NovoPen II and insulin Protaphane HM Penfill. 1988 ·PubMed ·Klaus Kølendorf, Henning Beck‐Nielsen, (unknown)	8
8	The effect of alprenolol on serum myoglobin levels in acute myocardial infarction 1984 ·Scandinavian Journal of Clinical and Laboratory Investigation ·(unknown), Søren Rasmussen, Klaus Kølendorf, Erik Christiansen	2
9	Absorption and Miscibility of Regular Porcine Insulin After Subcutaneous Injection of Insulin-treated Diabetic Patients 1983 ·Diabetes Care ·Klaus Kølendorf, (unknown), T. Deckert	12
10	Correlation between the Routine 6-Min. C-Peptide Value and the AUC after I.V. Glucagon Injection in NIDDM Patients 1982 ·Hormone and Metabolic Research ·Klaus Kølendorf, Birger Thorsteinsson, P Billesbølle, Sanne Kellebjerg Poulsen	4
11	Smoking reduces insulin absorption from subcutaneous tissue. 1982 ·BMJ ·P Klemp, B Staberg, Sten Madsbad, Klaus Kølendorf	43
12	Absorption of NPH‐Insulin from Subcutaneous Tissue: A Methodological Study in Pigs 1982 ·Acta Pharmacologica et Toxicologica ·T. Deckert, Bruno Hansen, Klaus Kølendorf, J. S. D. Poulsen, (unknown)	9
13	Collimation of portable cadmium telluride detectors for biotelemetry 1982 ·The International Journal of Applied Radiation and Isotopes ·(unknown), B Staberg, Klaus Kølendorf	6
14	Serum 3'-monoiodothyronine levels in normal subjects and in patients with thyroid and non-thyroid disease 1981 ·European Journal of Endocrinology ·C. Kirkegaard, Jens Faber, (unknown), Klaus Kølendorf, Helene Thomsen, I B Lumholtz, K. Siersbæk‐Nielsen, Th. Friis	1
15	A portable infusion pump, programmable with 16 rates. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), Klaus Kølendorf, (unknown), Karsten Juhl Jørgensen	8
16	THE INFLUENCE OF CHRONIC RENAL FAILURE ON SERUM AND URINARY THYROID HORMONE LEVELS 1978 ·European Journal of Endocrinology ·Klaus Kølendorf, (unknown), (unknown)	28
17	Diazoxide in the Management of Severe Hypertension 1975 ·Acta Medica Scandinavica ·(unknown), Klaus Kølendorf	1
18	LACTIC ACIDOSIS IN EPINEPHRINE POISONING 1974 ·Acta Medica Scandinavica ·Klaus Kølendorf, (unknown)	30
19	PTC Taste Sensitivity in Toxic Diffuse Goitre 1972 ·Human Heredity ·(unknown), (unknown), Klaus Kølendorf	12
20	INSULIN SECRETION AFTER TOLBUTAMIDE AND AFTER SECRETIN IN PATIENTS WITH PANCREATIC DISEASES 1972 ·Acta Medica Scandinavica ·T. Deckert, Klaus Kølendorf, (unknown), H. Worning	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact